Patients searching for Fluoroscopy-Guided Injections Gastonia NC can access provider-guided knee and shoulder injection care through Joint Health Solutions. Fluoroscopy creates real-time X-ray images that can help a clinician visualize bone structures, identify the intended joint space, and guide needle placement during selected procedures.
Fluoroscopy is not necessary for every injection. The appropriate guidance method depends on the affected joint, anatomy, treatment being considered, medical history, and findings from the clinical evaluation.
Joint Health Solutions serves adults traveling from Gastonia and Gaston County at its clinic at 9350 Benfield Road, #109, Charlotte, NC 28269. The practice does not operate a physical clinic in Gastonia.
Medically reviewed by: Dr. Jeffrey Galvin & Ariel Curtis, FNP-C
Fluoroscopy-guided injections use real-time X-ray imaging to help a qualified provider guide a needle into a selected knee or shoulder joint space. This guidance can be considered when clear visualization of bone anatomy or confirmation of needle position is important. Depending on the joint and clinical findings, an injection can include corticosteroid medication, knee hyaluronic acid, or another approved treatment. Fluoroscopy involves radiation exposure, and some procedures use contrast material. It does not rebuild cartilage, reverse arthritis, guarantee pain relief, or prevent future surgery.
Fluoroscopy is a medical imaging method that produces a continuous or pulsed sequence of X-ray images. Unlike a single static X-ray, it allows the provider to observe the position of instruments and relevant anatomy while a procedure is taking place.
During a joint injection, fluoroscopy can help the provider identify bony landmarks and guide the needle toward the intended joint space. A small amount of contrast material can sometimes be used to confirm that the needle has entered the appropriate location before the selected medication is administered.
Fluoroscopy clearly shows bone structures and joint-space landmarks, supporting accurate access when anatomy is difficult to navigate.
The provider can monitor the needle during the procedure and guide it toward the intended joint space.
A small amount of contrast can help confirm joint access before medication is delivered. Patient history and potential risks are reviewed first.
Fluoroscopy is used only when appropriate. The provider may recommend fluoroscopy, ultrasound, or another guidance method based on the planned procedure.
Fluoroscopy and ultrasound are both used to support image-guided procedures, but they create images in different ways and emphasize different anatomical structures.
| Consideration | Fluoroscopy | Ultrasound |
|---|---|---|
| Imaging Method | Uses real-time X-ray imaging. | Uses high-frequency sound waves. |
| Structures Commonly Visualized | Bone landmarks, joint spaces, needle position, and contrast distribution. | Tendons, muscles, fluid, blood vessels, soft tissue, and needle movement. |
| Radiation | Uses ionizing radiation. | Does not use ionizing radiation. |
| Contrast Material | Can be used to confirm access during selected procedures. | Usually does not require X-ray contrast. |
| Potential Role | Can support access to selected joints when bone anatomy or contrast confirmation is important. | Can support procedures involving superficial joints, soft tissue, fluid, or structures visible by ultrasound. |
| Important Limitation | Radiation and possible contrast exposure must be considered. | Image quality and visibility can depend on depth, anatomy, and the structure being targeted. |
Neither method is automatically superior for every patient. The appropriate choice depends on the affected joint, treatment plan, provider judgment, and individual medical factors.
Fluoroscopy-guided joint injections can be considered for selected knee and shoulder conditions when an injection is clinically appropriate and the provider determines that X-ray guidance would be useful.
A fluoroscopy-guided knee injection can be discussed for selected patients with:
Knee pain can also result from tendon problems, ligament injuries, meniscus conditions, infection, fracture, referred pain, or other causes. An injection should not be selected until the symptoms and relevant medical history have been evaluated.
Fluoroscopy can be considered for selected injections into the glenohumeral shoulder joint. Conditions and symptom patterns that can prompt an evaluation include:
Not all shoulder pain begins inside the joint. Rotator cuff disorders, bursitis, instability, neck-related symptoms, fractures, and other conditions require different evaluation and treatment pathways.
The decision to perform an injection involves more than selecting an imaging method. The provider also considers:
Fluoroscopy-guided care on this page refers only to approved knee and shoulder joint procedures. It does not include spine, epidural, facet, sacroiliac, nerve-block, hip, hand, wrist, elbow, or ankle procedures.
The medication or treatment used during an image-guided injection should be selected according to the diagnosis, affected joint, current evidence, previous treatment, and individual risk factors.
Fluoroscopy may be considered for selected knee-joint injections when visualization of bone landmarks, altered anatomy, joint-space access, or contrast confirmation would add value to the planned procedure. The medication or treatment should be selected according to the diagnosis, previous care, health risks, and current evidence. Fluoroscopy is not required for every knee injection.
A glenohumeral shoulder-joint injection may be guided with fluoroscopy when visualization of bone landmarks or confirmation of joint-space access is clinically useful. An intra-articular injection is not a substitute for evaluating rotator cuff injury, bursitis, instability, fracture, infection, neurological weakness, or symptoms referred from the neck.
Corticosteroid medication can be considered for short-term symptom support in selected patients with inflammatory or arthritis-related joint pain. The medication is intended to reduce inflammation and improve symptoms; it does not rebuild cartilage or repair damaged tendons.
The number and timing of injections require individualized review. Repeated injections are not automatically appropriate and can involve joint-specific and systemic risks.
Hyaluronic acid injections are sometimes considered for selected patients with knee osteoarthritis. They are intended to support symptom management within the knee joint.
Professional recommendations differ, and AAOS does not recommend hyaluronic acid for routine use in symptomatic knee osteoarthritis. Patient selection should therefore be individualized. Hyaluronic acid does not regrow cartilage, reverse arthritis, or guarantee that knee surgery will be avoided.
Hyaluronic acid should not be promoted as a treatment for shoulder osteoarthritis because clinical guidance has not demonstrated benefit for that use.
Platelet-rich plasma is prepared from a patient’s own blood and contains a concentrated proportion of platelets. It can be discussed for selected knee osteoarthritis patients after the potential benefits, costs, uncertainties, and alternatives are reviewed.
Evidence for knee osteoarthritis remains limited, and results vary. PRP should not be described as regenerating cartilage, reversing arthritis, permanently healing a joint, or guaranteeing avoidance of surgery.
Reliable evidence is insufficient to recommend PRP as an established treatment for glenohumeral shoulder osteoarthritis.
Toradol is the brand name commonly associated with ketorolac, a nonsteroidal anti-inflammatory medication. A Toradol IM injection is administered into a muscle, not into the knee or shoulder joint.
It is not a fluoroscopy-guided procedure and should not be presented as chronic arthritis treatment. Ketorolac can be considered only for short-term acute-pain support when medically appropriate. It has important gastrointestinal, kidney, cardiovascular, and bleeding risks and requires medication screening.
The treatment and guidance method should be selected separately. Fluoroscopy helps guide selected procedures, while cortisone, knee hyaluronic acid, knee PRP, and Toradol IM have different purposes, evidence bases, risks, and limitations.
| Approach | Commonly Considered For | Typical Goal | Evidence Considerations | Important Limitations |
|---|---|---|---|---|
| Corticosteroid Joint Injection | Selected arthritis-related or inflammatory joint symptoms. | Short-term reduction of pain and inflammation. | Can provide short-term symptom support for selected knee osteoarthritis patients. | Does not repair cartilage; frequency and repeat use require individualized review. |
| Knee Hyaluronic Acid Injection | Selected knee osteoarthritis patients. | Support knee symptom management. | Professional recommendations differ; not recommended by AAOS for routine use. | Knee only; does not rebuild cartilage and should not be promoted for shoulder osteoarthritis. |
| Knee PRP Therapy | Selected knee osteoarthritis patients after evidence review. | Support pain and function. | Evidence remains limited and outcomes vary. | Does not prove structural regeneration or arthritis reversal. |
| Fluoroscopy Guidance | Selected knee or shoulder procedures requiring clearer bone or joint-space visualization. | Support controlled needle placement. | Useful when X-ray visualization or contrast confirmation is clinically relevant. | Involves radiation and is not necessary for every injection. |
| Toradol IM Injection | Selected short-term acute-pain situations. | Systemic short-term pain support. | Medication decisions depend on medical history, kidney function, bleeding risk, and other factors. | Injected into muscle, not the joint; not a fluoroscopy-guided procedure. |
These features can support procedure planning and needle placement, but they do not guarantee clinical improvement, perfect placement, or freedom from complications.
The provider can observe bone landmarks, the needle, and relevant joint-space anatomy during the procedure.
Fluoroscopy helps the provider guide the needle toward the selected location instead of relying only on external landmarks.
Contrast material can sometimes provide additional confirmation that the needle is positioned within the intended joint space.
Image guidance can be useful when arthritis, altered anatomy, previous surgery, body structure, or limited surface landmarks make access more challenging.
The technology supports delivery of the selected medication to the planned anatomical area. It does not determine whether the medication will produce a particular clinical result.
The imaging method creates a clear procedural framework that supports consistent positioning, visualization, and treatment delivery.
Potential concerns include:
Radiation exposure should be limited to what is medically necessary. Patients who are pregnant or could be pregnant should inform the clinical team before fluoroscopy is used.
People taking anticoagulants or antiplatelet medications need individualized instructions. Prescribed medication should not be stopped without appropriate medical direction.
Contact a medical professional promptly for concerning symptoms after an injection, including:
Emergency symptoms require urgent assessment rather than waiting for a routine follow-up appointment.
There is no single duration that applies to every fluoroscopy-guided injection. Fluoroscopy guides the procedure; it does not control how the body responds to the medication.
The response can depend on:
Some patients notice meaningful symptom improvement, while others receive limited or no benefit. Improvement in pain or function does not prove cartilage restoration or structural healing.
Follow-up should focus on changes in pain, movement, daily activity, sleep, walking tolerance, work demands, and treatment goals. If the response is inadequate, the next step can include reconsidering the diagnosis, modifying conservative care, selecting another appropriate treatment, or recommending orthopedic evaluation.
Treatment begins with a clinical review rather than automatically scheduling an injection. The provider considers symptoms, medical history, previous treatment, medication risks, and functional goals.
Fluoroscopy is selected when it adds value to the planned knee or shoulder procedure. It is not presented as necessary for every patient.
Cortisone, selected knee hyaluronic acid injections, and knee PRP therapy are discussed according to the affected joint, evidence, limitations, and individual circumstances.
Injection care can be integrated with activity modification, physical therapy, low-impact exercise, knee bracing, nutrition and weight support, knee arthrocentesis when appropriate, and orthopedic referral.
Patients receive realistic information about uncertainty, medication risks, evidence limitations, and the difference between symptom relief and structural joint repair.
Jeffrey Galvin, MD, serves as Medical Director, and Ariel Curtis, FNP-C, provides joint-injection-focused care. Patients receive provider-guided evaluation, treatment education, safety screening, and referral guidance when appropriate.
Joint Health Solutions provides a defined care pathway for patients traveling from Gastonia and surrounding Gaston County communities to the Charlotte clinic.
A fluoroscopy-guided joint injection uses real-time X-ray imaging to help a provider guide a needle toward a selected joint space. Contrast material can sometimes be used to confirm the position before medication is administered. Fluoroscopy is a procedural guidance method rather than a treatment itself. The medication, expected goal, risks, and alternatives depend on the affected joint and clinical findings.
No. Fluoroscopy uses X-rays and is particularly useful for visualizing bone landmarks, joint spaces, needles, and contrast distribution. Ultrasound uses sound waves and can show muscles, tendons, fluid, blood vessels, and other soft tissues without ionizing radiation. The provider selects the guidance method according to the joint, anatomical target, planned procedure, and patient-specific considerations.
They are commonly performed medical procedures, but no injection is risk-free. Potential concerns include pain, bruising, bleeding, infection, medication reactions, contrast reactions, radiation exposure, and lack of improvement. The provider should review medications, allergies, pregnancy status, active infection, bleeding risk, and relevant health conditions before deciding whether the procedure is appropriate.
Radiation exposure varies according to the procedure, equipment, anatomy, and imaging time. It should therefore not be described with a universal comparison or fixed dose. The clinical team should use only the imaging necessary to complete the procedure. Patients who are pregnant or could be pregnant should disclose this before fluoroscopy is considered.
No. Contrast material is used only when it is clinically appropriate for the procedure. It can help the provider confirm access to the intended joint space. Patients should report previous contrast reactions, kidney problems, pregnancy, and relevant allergies. The provider determines whether contrast is necessary and whether additional precautions or another approach should be considered.
Possibly, but the decision requires individualized review. The provider needs to know the medication, dose, reason it was prescribed, bleeding history, and planned procedure. Do not stop warfarin, apixaban, rivaroxaban, clopidogrel, aspirin, or another prescribed medication on your own. Medication instructions should come from the appropriate prescribing and procedural clinicians.
Appointment length depends on the evaluation, joint, preparation, medication, contrast use, and monitoring needs. The injection portion can be relatively brief, but time must also be allowed for medical review, consent, positioning, sterile preparation, aftercare instructions, and questions. The scheduling team can explain what to expect for the specific procedure being considered.
The response depends primarily on the medication and underlying condition, not the fluoroscopy itself. Some treatments can produce earlier symptom changes, while others require more time or provide no meaningful improvement. Temporary soreness can occur after an injection. Patients should follow their individualized instructions and contact the clinic if symptoms become severe or concerning.
There is no universal number that is appropriate for every patient. The decision depends on the medication, diagnosis, affected joint, previous response, medical risks, and alternative treatments. Repeated corticosteroid injections require particular caution. An injection should not be repeated automatically simply because a previous procedure was performed.
Appointments for patients traveling from Gastonia are held at Joint Health Solutions, 9350 Benfield Road, #109, Charlotte, NC 28269. Joint Health Solutions does not operate a physical clinic in Gastonia. Patients can call 704-833-3566 to discuss scheduling, the purpose of the evaluation, and what records or medication information to bring. The team can also explain whether an image-guided injection evaluation may be appropriate for the symptoms being reported.
Schedule an evaluation to discuss the source of your knee or shoulder symptoms, whether an injection is appropriate, and whether fluoroscopy adds value to the planned procedure. Call 704-833-3566 or use the Joint Health Solutions Contact Us page to request an appointment.
